Data as of Jan 23
| -1.08 / -2.35%|
The 4 analysts offering 12-month price forecasts for Enanta Pharmaceuticals Inc have a median target of 49.00, with a high estimate of 55.00 and a low estimate of 41.00. The median estimate represents a +9.08% increase from the last price of 44.92.
The current consensus among 5 polled investment analysts is to Buy stock in Enanta Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.